tiprankstipranks
Aveo Pharmaceuticals (AVEO)
NASDAQ:AVEO

AVEO Pharma (AVEO) Financial Statements

0 Followers

AVEO Pharma Financial Overview

AVEO Pharma's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; AVEO Pharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 30.45M$ 25.30M$ 20.92M$ 17.65M$ 15.17M
Gross Profit$ 26.48M$ 22.24M$ 18.49M$ 15.61M$ 13.43M
EBIT$ -2.17M$ -7.15M$ -9.01M$ -6.10M$ -9.21M
EBITDA$ -2.15M$ -7.14M$ -8.99M$ -6.09M$ -9.20M
Net Income Common Stockholders$ -3.27M$ -8.32M$ -10.20M$ -7.25M$ -10.37M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 77.40M$ 77.16M$ 79.04M$ 87.33M$ 94.02M
Total Assets$ 101.23M$ 98.11M$ 98.22M$ 105.34M$ 109.09M
Total Debt$ 38.68M$ 38.43M$ 38.20M$ 37.97M$ 33.41M
Net Debt$ -38.72M$ -38.73M$ -40.84M$ -49.35M$ -60.61M
Total Liabilities$ 72.39M$ 67.52M$ 61.27M$ 59.47M$ 57.85M
Stockholders Equity$ 28.84M$ 30.59M$ 36.94M$ 45.87M$ 51.23M
Cash Flow-
Free Cash Flow$ 194.00K$ -2.45M$ -8.22M$ -12.18M$ -8.07M
Operating Cash Flow$ 194.00K$ -2.45M$ -8.22M$ -12.18M$ -8.07M
Investing Cash Flow$ 7.00M$ -1.79M$ 11.52M$ 8.36M$ 2.97M
Financing Cash Flow$ 36.00K$ 561.00K$ 0.00$ 5.52M$ -790.00K
Currency in USD

AVEO Pharma Earnings and Revenue History

AVEO Pharma Debt to Assets

AVEO Pharma Cash Flow

AVEO Pharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis